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Abstract: During fiscal year 1986,40 out of 196 patients (21(10) developed 
hyperamylasemia following orthotopic liver transplantation. The place-
ment of a retropancreatic aortohepatic arterial interposition graft was 
associated with hyperamylasemia (p < 0.025). Eight patients (20%) de-
veloped clinically significant acute pancreatitis and its sequelae; abscesses 
and pseudocysts each in 2. Pancreatitis was attributable to the retropancrea-
tic arterial graft in 4, viral infection in 2 and obstruction of the pancreatic 
duct in 1 patient. All 4 patients with arterial graft-related pancreatitis 
exhibited poor graft function immediately postoperatively, of whom 2 
required retransplantation - both of which failed to function. Five 
patients died (63'X)); 2 from primary graft non-function, 2 due to sepsis 
and 1 from systemic cytomegalovirus infection. We conclude that acute 
pancreatitis after liver transplantation is a life-threatening complication 
which is often associated with graft non-function. 
Thomas E. Starzl 
Department of Surgery, University Health Center 
of Pittsburgh, University of Pittsburgh, Pitts-
burgh, Pennsylvania, U.S.A. and Department of 
Surgery II, Faculty of Medicine, Kyushu Univer-
sity, Fukuoka, Japan. 
Key words: liver transplantation - pancreatitis -
pseudocyst - abscess 
Katsuhiko Yanaga, M.O., Dept. of Surgery II. Fac-
ulty of Medicll1e, Kyushu University, Higashi-ku. 
Fukuoka 812, Japan 
Accepted for publication 14 October 1991 
Introduction 
Since first reported in 1964 (1), pancreatitis has 
been known as a rare but serious complication of 
organ transplantation. After renal transplantation, 
the incidence of acute pancreatitis varies from 2 to 
7% and a mortality rate ranges from 17 to 70% 
(2-7). In cardiac transplantation, rates of 19% and 
2YYt, each are reported (8). Pancreatic compli-
cations following transplantation of these organs 
have been attributed to multiple factors including 
hypercalcemia (2-5), uremia (4), gallstones (4, 7), 
surgical trauma (7, 9), corticosteroids (2-5), aza-
thioprine (3 5), cyclosporine toxicity (8), cytomeg-
alovirus (CMV) or hepatitis B virus (HBV) infec-
tion (2, 4. 10) and low perfusion status of the 
pancreas during cardiopulmonary bypass (8). In 
liver transplantation, on the other hand, hepatitis 
B-related liver disease is the only known factor 
associated with pancreatitis long-term after trans-
plant (11). The purpose of this study was to evalu-
ate the clinical presentation of pancreatitis and 
its sequelae after orthotopic liver transplantation 
(OLTx), and to identify factors pertinent to the 
development of this serious complication. 
Supported by Research Grants from the Veterans Administra-
tion and Project Grant No. AM 29961 from the National 
Institute of Health, Bethesda, Maryland. 
126 
Patients and methods 
Charts of 196 adult patients who underwent 233 
OLTx during a 1-yr period between July 1, 1986 
and June 30, 1987 at the Presbyterian University 
Hospital of Pittsburgh were reviewed. Their ages 
ranged from 19 to 76 yr with a mean of 45 yr, and 
85 were male (43%). The indications for OLTx 
consisted of postnecrotic cirrhosis in 101, (21 al-
coholic, 80 non-alcoholic), primary biliary cirrhosis 
in 41, primary sclerosing cholangitis in 20, neo-
plasm in 10 and others in 24 patients. None had 
hyperlipidemia nor evidence of hyperpara-
thyroidism. One patient was excluded from the 
study due to pre-existing acute pancreatitis at the 
time of OLTx. 
All allografts were preserved in Euro-Collins' 
solution (4C) and OLTx was performed with the 
use of standard techniques: gastroduodenal artery 
was ligated routinely, while the splenic artery was 
left intact. When the inflow artery was judged to 
be inadequate, an aortohepatic interposition graft 
(AHIG) was placed through a retropancreatic tun-
nel from the infrarenal aorta (12). If the portal 
vein was thrombosed, a venous graft was placed 
between the donor portal vein and the recipient 
meso splenic confluence as an interposition graft 
(13). Veno-venous bypass was used routinely in all 
but 2 cases. Bile duct reconstruction consisted of 
choledocho-choledochostomy (114 transplants, 
49%) or Roux-en-Y choledocho-jejunostomy (110 
transplants, 47%), while, this could not be com-
pleted in the other 9 due to various technical prob-
lems. An intraoperative cholangiograms were 
taken routinely after completion of a choledocho-
choledochostomy. Although a retained and impac-
ted cystic duct stone was found in 1 patient, none of 
the intra- or postoperative cholangiograms showed 
evidence of retained common duct stones. The allo-
graft gallbladder was excised routinely following 
bile duct reconstruction. 
Posttransplant immunosuppression consisted of 
cyclosporine and steroids. Steroid therapy consist-
ed of i.v. bolus of methylprednisone (1 gram, im-
mediately before reperfusion) and postoperative 
rapid tapering of i.v. methy1prednisone, from 200 
mgl d to 20 mgl d in 6 d, followed by maintenance 
with methylprednisone i.v. or prednisone p.o. at 20 
mgl d. Rejection episodes were treated with a bolus 
of methyl prednisone, 1 g i.v., followed by the afore-
mentioned recycle of steroids. Steroid-resistant re-
jection was treated with Orthoclone OKT3:E (Or-
tho Pharmaceutical Co., Raritan, NJ). 
Postoperatively, a serum amylase was measured 
daily in the intensive care unit, and then twice 
weekly in the ward. Hyperamylasemia was defined 
as a serum amylase level over 400 IU 11 (normal 
0-100 lUll). None of the patients developed clin-
ical evidence of parotitis postoperatively. When 
pancreatitis was suspected, computed tomography 
(CT) of the abdomen was performed. 
The diagnosis of pancreatitis was made when the 
following criteria were satisfied: 1) direct evidence 
of pancreatitis, i.e., swollen pancreas with saponifi-
cation of the adipose tissue on exploratory lapar-
otomy or retransplantation, 2) autopsy findings, 
and 3) hyperamylasemia associated with symptoms 
and signs of pancreatitis as well as findings of 
pancreatitis on CT. In patients with pancreatitis, 
CT was performed periodically to evaluate the 
changes in the pancreas, and to rule out the devel-
opment of its sequelae. 
Primary non-function was defined as inability of 
the graft to sustain metabolic homeostasis of the 
recipient during the 1st postoperative wk, as mani-
fested by grade III or IV coma, coagulopathy with 
the prothrombin time over 20 sec, high transamin-
ases, progressive or persistent hyperbilirubinemia 
and rapid development of renal failure, which re-
sulted in retransplantation or death of the recipi-
ent. Poor graft function was defined as SGOT over 
3500 IU 11, SGPT over 2500 IU 11 or prothrombin 
time over 20 sec during the first 5 postoperative d 
but without the need for retransplantation. 
In patients with fever of undetermined origin or 
with leukocytopenia, viral studies were performed, 
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which consisted of viral titers, buffy coat, urine 
and throat cultures as well as a needle liver biopsy 
for a hematoxylin-eosin stain and immunohisto-
chemical stains for viral antigens. 
Chi-square test and one-way analysis of variance 
were used for the statistical analyses in this study. 
Results 
Of the 40 patients with posttransplant hyperamy-
lasemia, 8 (20%) developed clinically significant 
pancreatitis (Table 1). The diagnosis of pancreatitis 
was established on exploratory laparotomy or re-
transplantation in 6 patients (Case 1-4, 6, 8), at 
autopsy in 1 (Case 7), and by hyperamylasemia 
associated with typical presentation of pancreatitis 
and positive CT findings in 1 patient (Case 5). 
Their ages varied from 26 to 65 yr (mean 46), and 
4 were male (50%). Their peak serum amylase levels 
varied from 536 to 2900 IU II, with a mean of 2303 
IU /l. In 4 patients (Case 1-4), the occurrence of 
pancreatitis was attributable to the placement of 
the AHIG (Fig. 1). Other causes included obstruc-
tion of the pancreatic duct by the distal limb of a 
migrated T-tube (Case 5) and viral infection due 
to CMV (Case 7) or HBV (Case 6). In case 8, who 
showed hyperamylasemia immediately postopera-
tively and developed pancreatic pseudocysts, no 
obvious causative factor was identified. 
Of the 4 patients (Case 1-4) in whom acute 
pancreatitis was diagnosed on post-transplant d 1 
or 2, 2 (Case 1, 2) developed primary graft non-
function, while the other 2 (Case 3, 4) exhibited 
extremely poor allograft function with a high pro-
thrombin time, SGOT and SGPT as well as persist-
ent hyperbilirubinemia. The development of renal 
failure was another feature among these patients. 
Case 1 and 2 underwent retransplantation but both 
again failed to function. 
The sequelae of pancreatitis consisted of the for-
mation of pseudocysts in 2 patients (Case 3, 8), 
a pancreatic abscess in 1 (Case 2) and a large 
retroperitoneal abscess in 1 (Case 4). The pseudo-
cysts in both patients became infected. Overall, 
infectious complications of the pancreatitis oc-
curred in 4 patients (50%), the pathogen of which 
consisted of Staphylococcus aureus in 1, and Pseu-
domonas aeruginosa and P. maltophilia in another. 
On the other two occasions, the pus was culture-
negative. 
Treatment of pancreatitis consisted of bowel rest 
and intravenous hyperalimentation. In Case 6, re-
moval of the migrated T-tube resulted in rapid 
disappearance of the symptoms and normalization 
of the serum amylase. The abscesses and infected 
pseudocysts were drained surgically or under CT 
guidance. Five patients died (63%); 2 from primary 
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Table 1. Clinical data of patients who developed pancreatitis after OLTx 
POOH Highest 
Agel on Amylase Clinical Outcome 
Case Sex Diagnosis Cause (lUll) Presentation Sequelae Treatment 
lAG 1.764 PGNFN none OLTx IV died of PGNFN 1 371M 2 drainage, OLTx 1\ died of PGNFN 
2 62/F 2 lAG 535 PGNFN pancreatic abscesses (14)' 
alive and well 
3 261M lAG 1.193 poor GFN, fever, hypocal- pseudocysts (32)" in- drainage 
cemia fected pseudocysts (80') 
died of MOF 
4 43/F 2 lAG 7.121 poor GFN ARF, semicoma retroperitoneal abscess drainage (15)' 
alive and well 
5 49/F 71 migrated 2.900 fever, back pain none removal of T-tube 
T-tube 
died of MOF 6 58 /M 108 HBV 1.889 stupor, acute abdomen none N PO, NG suction IV lIuid 
7 311M 41 (au- CMV 1.072 systemic CMV infection none died of systemic CMV in-
topsy) fection 
8 65/F 56 unknown (1.952)' pancreatic pseudocysts infected pseudocysts drainage alive and well (62)' 
( ),=number of postoperative day; ( t=data on the 3rd postoperative d; OLTx=orthotopic liver transplantation; POD#=postoperative day; IAG=iliac artery 
graft PGNFN=primary graft non-function; GFN graft-function; ARF=acute renal failure; MOF=multiple organ failure; HBV=hepatitis B virus; CMV=cytomegaloVifus. 
graft non-function (Case I, 2), 2 from multiple 
organ failure (Case 4, 6), and 1 from systemic CMV 
infection (Case 7). 
All 8 patients with clinically proven pancreatitis 
in our series received no azathioprine, showed no 
evidence of common duct stones, and none demon-
strated evidence of cyclosporin toxicity as mani-
fested by a high blood cyclosporin level in combi-
nation with mental confusion, severe tremor and 
renal failure. Furthermore, none of these patients 
has had chronic renal failure prior to OLTx. One 
patient (Case 5) underwent splenectomy for patent 
Warren shunt during OLTx. 
In order to identify the cause of hyperamy-
lasemia in 40 patients following OLTx, the follow-
ing peri operative variables were correlated with 
hyperamylasemia; the placement of an artery or 
portal vein graft , methods of bile duct reconstruc-
Fig . 1. Computed tomogram of Case 4 on the posttranspiant d 
8. The entire pancreas is swollen . 
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tion and operative blood loss (Table 2). A statisti-
cally significant correlation was identified between 
hyperamylasemia and the placement of an ARlO 
during OLTx (p < 0.025, X2 = 6.38), while the place-
ment of a portal vein graft or methods of bile duct 
reconstruction did not. The operative blood loss 
tended to be higher among the patients with hyper-
amylasemia but this did not achieve statistical sig-
nificance. 
Among the 32 patients who developed asympto-
matic hyperamylasemia following OLTx, the elev-
ation of the amylase was attributable to accidental 
injury of the portal vein and the pancreas during 
portal vein cannulation for veno-venous bypass in 
I (3%) and acute renal failure in 3 patients (9%). 
Table 2. Correlation between hyperamylasemia and pertinent clinical variables 
Serum amylase (fUll) 
Variable ~ 4MM < 400 Total 
Aortohepatic interposition graft 
yes' 12 (34.3%) 23 (657%) 35 (100%) 
no' 32 (16.2%) 166 (83.8%) 198 (100%) 
Portaf vein graft 
yes 2 (18.2%) 9 (81 .8%) 11 (100%) 
no 38 (17.1%) 184 (82.9%) 222 (100%) 
Method of bile duct 
reconstruction 
C-C 93 (816%) 21 (18.4%) 114 (100%) 
C-J 87 (79.1%) 23 (20.9%) 110 (100%) 
Operative blood loss (U) 
mean±S.D. 267 ±33.3t 18.2±247t 
range 3--250 1-155 
'p < 0.025 (X1=6.38); ·p=0.06 (One-way analysis of variance); C-C=chole-
dochocholedochostomy; C-J = choledochojejunostomy. 
In the remaining 32 grafts of 28 patients (88%), no 
definitive causative factor could be identified. 
Discussion 
Acute pancreatitis in this series can be classified 
into two categories, i.e., early (Case 1--4) and late 
(Case 5-8). Pancreatitis late after OLTx seems to 
be attributable to causes which are not specific for 
OLTx. On the other hand, a peculiar feature of 
pancreatitis early after OLTx was related to the 
placement of the AHIG and presented with 
compromised graft function. 
Factors for the development of acute pancreatitis 
early after OLTx include direct compression of the 
pancreas for the exposure of the hepatic hilus, sub-
optimal splanchnic decompression in venovenous 
bypass, splenectomy mainly for patent Warren 
shunt (14), the placement of AHIG, intraoperative 
cholangiography and intra- or postoperative im-
munosuppreSSlOn. 
In our series, all 4 instances of pancreatitis early 
after OLTx were associated with the placement of 
AHIG. During the period studied, the AHIG was 
placed exclusively retropancreatic, by blunt finger 
dissection of the plane between the pancreas and 
the left renal vein. It seems highly likely that the 
manipulation of the pancreas in such a maneuver 
is at least partly responsible for the development 
of aucte pancreatitis. The high correlation between 
hyperamylasemia and the placement of AHIG in 
this series seems to reinforce such speculation. 
For the arterial reconstruction in OLTx, anatom-
ical reconstruction has always been the first choice. 
When the arterial flow after reconstruction is in 
question, it should be objectively evaluated with 
the use of a flowmeter (15). When the flow is 
suboptimal, less than 200 ml/min in adults, the use 
of a AHIG is indicated to avoid hepatic artery 
thrombosis (16). For the placement of AHIG, we 
now place AHIG antepancreatic, rather than retro-
pancreatic, as a "jump" graft through the mesoco-
lon (17). Since we adopted this technique, we have 
encountered far fewer incidences of acute pancrea-
titis early after OLTx. 
Although acute pancreatitis is a known sequela 
of splenectomy, we have not experienced such a 
complication (14). Reflux of a radiopaque dye into 
the pancreatic duct is frequently observed on an 
intraoperative cholangiogram after choledochoch-
oledochostomy. This, however, does not seem to 
be a predisposing factor for post-OLTx hyper amy-
lasemia. 
As to the strong correlation between acute pan-
creatitis early after OLTx and poor allograft func-
tion, the pancreas has been known as a key organ 
to secrete hepatotrophic factors, of which insulin 
Pancreatitis after liver transplant 
seems to be the most important (18). Furthermore, 
the severity of acute pancreatitis has been known 
to correlate with elevated SGOT and hyperglyce-
mia (19). We believe that acute pancreatitis im-
mediately after OLTx is a clinical entity which 
can cause posttransplant graft non- or poor func-
tion. 
As to asymptomatic hyperamylasemia after 
OLTx, the incidence was 14.3(/'0 (24/196 patients), 
which is comparable to cardiac (19%) or non-car-
diac (10%) surgical procedures (20, 21). Since acute 
pancreatitis early after OLTx is associated with a 
very high mortality, it is extremely important to 
differentiate clinical pancreatitis from asymptoma-
tic hyperamylasemia. When hyperamy!asemia is 
encountered early after OLTx, renal function 
should be taken into consideration, and if normal 
or near nom1al, immediate measurement of serum 
lipase and emergency CT should be performed. 
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